Not much is expected from the earnings release on Monday, it is a matter of how much are the losses rather than any gains. The entire sector is overvalued and is simply a speculative growth play with limited financials for this growth to be projected. Aphria was one of the first medical marijuana companies that was profitable that was until major expenditure was required to scale up operations to create a supply chain for the blossoming recreational marijuana sector.